APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Veterinary Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Veterinary Drug Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchPet Veterinary Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Veterinary Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pet Veterinary Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Veterinary Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Veterinary Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pet Veterinary Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Veterinary Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Veterinary Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Veterinary Drug market include Bayer AG, Zoetis Animal Healthcare, Virbac Group, Vetoquinol, Orion Corporation, Merck Animal Health, Elanco Animal Health Inc., Dechra Pharmaceuticals Plc and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Veterinary Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Veterinary Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Veterinary Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Veterinary Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Veterinary Drug Segment by Company

Bayer AG

Zoetis Animal Healthcare

Virbac Group

Vetoquinol

Orion Corporation

Merck Animal Health

Elanco Animal Health Inc.

Dechra Pharmaceuticals Plc

Ceva

Boehringer Ingelheim International GmbH

Pet Veterinary Drug Segment by Type

Analgesics

Sedatives

Parasiticides

Anti-Inflammatory

Anti-Infectives

Others

Pet Veterinary Drug Segment by Application

Veterinary Hospitals

Veterinary Clinics

Drug Stores

Pet Veterinary Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Veterinary Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pet Veterinary Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Veterinary Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Veterinary Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Veterinary Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Veterinary Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Veterinary Drug industry.

Chapter 3: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pet Veterinary Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pet Veterinary Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Veterinary Drug Industry Trends Table 2. Pet Veterinary Drug Industry Drivers Table 3. Pet Veterinary Drug Industry Opportunities and Challenges Table 4. Pet Veterinary Drug Industry Restraints Table 5. Global Pet Veterinary Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Veterinary Drug Revenue Share by Company (2021-2026) Table 7. Global Pet Veterinary Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pet Veterinary Drug Sales Volume Share by Company (2021-2026) Table 9. Global Pet Veterinary Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pet Veterinary Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pet Veterinary Drug Key Company Manufacturing Base & Headquarters Table 12. Global Pet Veterinary Drug Company, Product Type & Application Table 13. Global Pet Veterinary Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Veterinary Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Analgesics Table 18. Significant Companies of Sedatives Table 19. Significant Companies of Parasiticides Table 20. Significant Companies of Anti-Inflammatory Table 21. Significant Companies of Anti-Infectives Table 22. Significant Companies of Others Table 23. Global Pet Veterinary Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pet Veterinary Drug Sales Volume by Type (2021-2026) & (k units) Table 25. Global Pet Veterinary Drug Sales Volume by Type (2027-2032) & (k units) Table 26. Global Pet Veterinary Drug Sales Volume Share by Type (2021-2026) Table 27. Global Pet Veterinary Drug Sales Volume Share by Type (2027-2032) Table 28. Global Pet Veterinary Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pet Veterinary Drug Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Pet Veterinary Drug Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Pet Veterinary Drug Sales Value Share by Type (2021-2026) Table 32. Global Pet Veterinary Drug Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Veterinary Hospitals Table 34. Significant Companies of Veterinary Clinics Table 35. Significant Companies of Drug Stores Table 36. Global Pet Veterinary Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Pet Veterinary Drug Sales Volume by Application (2021-2026) & (k units) Table 38. Global Pet Veterinary Drug Sales Volume by Application (2027-2032) & (k units) Table 39. Global Pet Veterinary Drug Sales Volume Share by Application (2021-2026) Table 40. Global Pet Veterinary Drug Sales Volume Share by Application (2027-2032) Table 41. Global Pet Veterinary Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Pet Veterinary Drug Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Pet Veterinary Drug Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Pet Veterinary Drug Sales Value Share by Application (2021-2026) Table 45. Global Pet Veterinary Drug Sales Value Share by Application (2027-2032) Table 46. Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Pet Veterinary Drug Sales by Region (2021-2026) & (k units) Table 48. Global Pet Veterinary Drug Sales Market Share by Region (2021-2026) Table 49. Global Pet Veterinary Drug Sales by Region (2027-2032) & (k units) Table 50. Global Pet Veterinary Drug Sales Market Share by Region (2027-2032) Table 51. Global Pet Veterinary Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Pet Veterinary Drug Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Pet Veterinary Drug Sales Value Share by Region (2021-2026) Table 54. Global Pet Veterinary Drug Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Pet Veterinary Drug Sales Value Share by Region (2027-2032) Table 56. Global Pet Veterinary Drug Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Pet Veterinary Drug Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Pet Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Pet Veterinary Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pet Veterinary Drug Sales by Country (2021-2026) & (k units) Table 61. Global Pet Veterinary Drug Sales Market Share by Country (2021-2026) Table 62. Global Pet Veterinary Drug Sales by Country (2027-2032) & (k units) Table 63. Global Pet Veterinary Drug Sales Market Share by Country (2027-2032) Table 64. Global Pet Veterinary Drug Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Pet Veterinary Drug Sales Value Market Share by Country (2021-2026) Table 66. Global Pet Veterinary Drug Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Pet Veterinary Drug Sales Value Market Share by Country (2027-2032) Table 68. Bayer AG Company Information Table 69. Bayer AG Business Overview Table 70. Bayer AG Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Bayer AG Pet Veterinary Drug Product Portfolio Table 72. Bayer AG Recent Development Table 73. Zoetis Animal Healthcare Company Information Table 74. Zoetis Animal Healthcare Business Overview Table 75. Zoetis Animal Healthcare Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio Table 77. Zoetis Animal Healthcare Recent Development Table 78. Virbac Group Company Information Table 79. Virbac Group Business Overview Table 80. Virbac Group Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Virbac Group Pet Veterinary Drug Product Portfolio Table 82. Virbac Group Recent Development Table 83. Vetoquinol Company Information Table 84. Vetoquinol Business Overview Table 85. Vetoquinol Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Vetoquinol Pet Veterinary Drug Product Portfolio Table 87. Vetoquinol Recent Development Table 88. Orion Corporation Company Information Table 89. Orion Corporation Business Overview Table 90. Orion Corporation Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Orion Corporation Pet Veterinary Drug Product Portfolio Table 92. Orion Corporation Recent Development Table 93. Merck Animal Health Company Information Table 94. Merck Animal Health Business Overview Table 95. Merck Animal Health Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Merck Animal Health Pet Veterinary Drug Product Portfolio Table 97. Merck Animal Health Recent Development Table 98. Elanco Animal Health Inc. Company Information Table 99. Elanco Animal Health Inc. Business Overview Table 100. Elanco Animal Health Inc. Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio Table 102. Elanco Animal Health Inc. Recent Development Table 103. Dechra Pharmaceuticals Plc Company Information Table 104. Dechra Pharmaceuticals Plc Business Overview Table 105. Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio Table 107. Dechra Pharmaceuticals Plc Recent Development Table 108. Ceva Company Information Table 109. Ceva Business Overview Table 110. Ceva Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Ceva Pet Veterinary Drug Product Portfolio Table 112. Ceva Recent Development Table 113. Boehringer Ingelheim International GmbH Company Information Table 114. Boehringer Ingelheim International GmbH Business Overview Table 115. Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio Table 117. Boehringer Ingelheim International GmbH Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Pet Veterinary Drug Distributors List Table 121. Pet Veterinary Drug Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Pet Veterinary Drug Product Image Figure 2. Global Pet Veterinary Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pet Veterinary Drug Sales (2021-2032) & (k units) Figure 5. Global Pet Veterinary Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pet Veterinary Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Analgesics Image Figure 10. Sedatives Image Figure 11. Parasiticides Image Figure 12. Anti-Inflammatory Image Figure 13. Anti-Infectives Image Figure 14. Others Image Figure 15. Global Pet Veterinary Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Pet Veterinary Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Veterinary Drug Sales Volume Share by Type (2021-2032) Figure 18. Global Pet Veterinary Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pet Veterinary Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pet Veterinary Drug Sales Value Share by Type (2021-2032) Figure 21. Veterinary Hospitals Image Figure 22. Veterinary Clinics Image Figure 23. Drug Stores Image Figure 24. Global Pet Veterinary Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Pet Veterinary Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Pet Veterinary Drug Sales Volume Share by Application (2021-2032) Figure 27. Global Pet Veterinary Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pet Veterinary Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Pet Veterinary Drug Sales Value Share by Application (2021-2032) Figure 30. Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Pet Veterinary Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Pet Veterinary Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Pet Veterinary Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Pet Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 35. North America Pet Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Pet Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Pet Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Pet Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Pet Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Pet Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 41. South America Pet Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Pet Veterinary Drug Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Pet Veterinary Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Pet Veterinary Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Pet Veterinary Drug Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Pet Veterinary Drug Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Sedatives
  • Parasiticides
  • Anti-Inflammatory
  • Anti-Infectives
  • Others
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Drug Stores
Companies covered
  • Bayer AG
  • Zoetis Animal Healthcare
  • Virbac Group
  • Vetoquinol
  • Orion Corporation
  • Merck Animal Health
  • Elanco Animal Health Inc.
  • Dechra Pharmaceuticals Plc
  • Ceva
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Veterinary Drug Sales Value (2021-2032)
  4. 1.2.2 Global Pet Veterinary Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Pet Veterinary Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pet Veterinary Drug Market Dynamics
  1. 2.1 Pet Veterinary Drug Industry Trends
  2. 2.2 Pet Veterinary Drug Industry Drivers
  3. 2.3 Pet Veterinary Drug Industry Opportunities and Challenges
  4. 2.4 Pet Veterinary Drug Industry Restraints
3 Pet Veterinary Drug Market by Company
  1. 3.1 Global Pet Veterinary Drug Company Revenue Ranking in 2025
  2. 3.2 Global Pet Veterinary Drug Revenue by Company (2021-2026)
  3. 3.3 Global Pet Veterinary Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Pet Veterinary Drug Average Price by Company (2021-2026)
  5. 3.5 Global Pet Veterinary Drug Company Ranking (2024-2026)
  6. 3.6 Global Pet Veterinary Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Pet Veterinary Drug Company Product Type and Application
  8. 3.8 Global Pet Veterinary Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pet Veterinary Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pet Veterinary Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pet Veterinary Drug Market by Type
  1. 4.1 Pet Veterinary Drug Type Introduction
  2. 4.1.1 Analgesics
  3. 4.1.2 Sedatives
  4. 4.1.3 Parasiticides
  5. 4.1.4 Anti-Inflammatory
  6. 4.1.5 Anti-Infectives
  7. 4.1.6 Others
  8. 4.2 Global Pet Veterinary Drug Sales Volume by Type
  9. 4.2.1 Global Pet Veterinary Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Pet Veterinary Drug Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Pet Veterinary Drug Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Pet Veterinary Drug Sales Value by Type
  13. 4.3.1 Global Pet Veterinary Drug Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Pet Veterinary Drug Sales Value by Type (2021-2032)
  15. 4.3.3 Global Pet Veterinary Drug Sales Value Share by Type (2021-2032)
5 Pet Veterinary Drug Market by Application
  1. 5.1 Pet Veterinary Drug Application Introduction
  2. 5.1.1 Veterinary Hospitals
  3. 5.1.2 Veterinary Clinics
  4. 5.1.3 Drug Stores
  5. 5.2 Global Pet Veterinary Drug Sales Volume by Application
  6. 5.2.1 Global Pet Veterinary Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pet Veterinary Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pet Veterinary Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pet Veterinary Drug Sales Value by Application
  10. 5.3.1 Global Pet Veterinary Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pet Veterinary Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pet Veterinary Drug Sales Value Share by Application (2021-2032)
6 Pet Veterinary Drug Regional Sales and Value Analysis
  1. 6.1 Global Pet Veterinary Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Veterinary Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Veterinary Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Pet Veterinary Drug Sales by Region (2027-2032)
  5. 6.3 Global Pet Veterinary Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pet Veterinary Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pet Veterinary Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pet Veterinary Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Pet Veterinary Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pet Veterinary Drug Sales Value (2021-2032)
  12. 6.6.2 North America Pet Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pet Veterinary Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Pet Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pet Veterinary Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pet Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pet Veterinary Drug Sales Value (2021-2032)
  21. 6.9.2 South America Pet Veterinary Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pet Veterinary Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pet Veterinary Drug Sales Value Share by Country, 2025 VS 2032
7 Pet Veterinary Drug Country-level Sales and Value Analysis
  1. 7.1 Global Pet Veterinary Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Veterinary Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pet Veterinary Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Pet Veterinary Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Pet Veterinary Drug Sales by Country (2027-2032)
  6. 7.4 Global Pet Veterinary Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pet Veterinary Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pet Veterinary Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pet Veterinary Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pet Veterinary Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pet Veterinary Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Pet Veterinary Drug Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Zoetis Animal Healthcare
  8. 8.2.1 Zoetis Animal Healthcare Company Information
  9. 8.2.2 Zoetis Animal Healthcare Business Overview
  10. 8.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Portfolio
  12. 8.2.5 Zoetis Animal Healthcare Recent Developments
  13. 8.3 Virbac Group
  14. 8.3.1 Virbac Group Company Information
  15. 8.3.2 Virbac Group Business Overview
  16. 8.3.3 Virbac Group Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Virbac Group Pet Veterinary Drug Product Portfolio
  18. 8.3.5 Virbac Group Recent Developments
  19. 8.4 Vetoquinol
  20. 8.4.1 Vetoquinol Company Information
  21. 8.4.2 Vetoquinol Business Overview
  22. 8.4.3 Vetoquinol Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vetoquinol Pet Veterinary Drug Product Portfolio
  24. 8.4.5 Vetoquinol Recent Developments
  25. 8.5 Orion Corporation
  26. 8.5.1 Orion Corporation Company Information
  27. 8.5.2 Orion Corporation Business Overview
  28. 8.5.3 Orion Corporation Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Orion Corporation Pet Veterinary Drug Product Portfolio
  30. 8.5.5 Orion Corporation Recent Developments
  31. 8.6 Merck Animal Health
  32. 8.6.1 Merck Animal Health Company Information
  33. 8.6.2 Merck Animal Health Business Overview
  34. 8.6.3 Merck Animal Health Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck Animal Health Pet Veterinary Drug Product Portfolio
  36. 8.6.5 Merck Animal Health Recent Developments
  37. 8.7 Elanco Animal Health Inc.
  38. 8.7.1 Elanco Animal Health Inc. Company Information
  39. 8.7.2 Elanco Animal Health Inc. Business Overview
  40. 8.7.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Portfolio
  42. 8.7.5 Elanco Animal Health Inc. Recent Developments
  43. 8.8 Dechra Pharmaceuticals Plc
  44. 8.8.1 Dechra Pharmaceuticals Plc Company Information
  45. 8.8.2 Dechra Pharmaceuticals Plc Business Overview
  46. 8.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Portfolio
  48. 8.8.5 Dechra Pharmaceuticals Plc Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Pet Veterinary Drug Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim International GmbH
  56. 8.10.1 Boehringer Ingelheim International GmbH Company Information
  57. 8.10.2 Boehringer Ingelheim International GmbH Business Overview
  58. 8.10.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Portfolio
  60. 8.10.5 Boehringer Ingelheim International GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Veterinary Drug Value Chain Analysis
  2. 9.1.1 Pet Veterinary Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Veterinary Drug Sales Mode & Process
  6. 9.2 Pet Veterinary Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Veterinary Drug Distributors
  9. 9.2.3 Pet Veterinary Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst